We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes.
- Authors
Raskin, Philip; Rendell, Marc; Riddle, Matthew C.; Dole, Jo F.; Freed, Martin I.; Rosenstock, Julio; Raskin, P; Rendell, M; Riddle, M C; Dole, J F; Freed, M I; Rosenstock, J; Rosiglitazone Clinical Trials Study Group
- Abstract
<bold>Objective: </bold>To determine the efficacy and safety of rosiglitazone (RSG) when added to insulin in the treatment of type 2 diabetic patients who are inadequately controlled on insulin monotherapy.<bold>Research Design and Methods: </bold>After 8 weeks of insulin standardization and placebo (PBO) run-in, 319 type 2 diabetic patients with mean baseline HbA(1c) > or = 7.5% (8.9 +/- 1.1 to 9.1 +/- 1.3) on twice-daily insulin therapy (total daily dose > or = 30 U) were randomized to 26 weeks of additional treatment with RSG (4 or 8 mg daily) or PBO. Insulin dose could be down- titrated only for safety reasons. The primary end point was reduction of HbA(1c) from baseline.<bold>Results: </bold>RSG 4 and 8 mg daily significantly improved glycemic control, which was unchanged on PBO. By intent-to-treat analysis, treatment with RSG 8 mg plus insulin resulted in a mean reduction from baseline in HbA(1c) of 1.2% (P < 0.0001), despite a 12% mean reduction of insulin dosage. Over 50% of subjects treated daily with RSG 8 mg plus insulin had a reduction of HbA(1c) > or = 1.0%. Neither total:HDL cholesterol nor LDL:HDL cholesterol ratios significantly changed with RSG treatment. Serious adverse events did not differ among groups.<bold>Conclusions: </bold>The addition of RSG to insulin treatment results in significant improvement in glycemic control and is generally well tolerated.
- Subjects
TYPE 2 diabetes; DIABETES; ALTERNATIVE medicine
- Publication
Diabetes Care, 2001, Vol 24, Issue 7, p1226
- ISSN
0149-5992
- Publication type
journal article
- DOI
10.2337/diacare.24.7.1226